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Abstract
Background and objective While decision support tools such as
decision aids can contribute to shared decision making, implement-
ing these tools in daily practice is challenging. To identify and
address issues around the use of decision support tools in routine
care, this study explores the views of men and general practitioners
on using a DA for early detection of prostate cancer.
Methods, setting and participants Group discussions and semi-
structured interviews were carried out with 43 men and 16 general
practitioners familiar with a previously developed decision aid. Data
were analysed using qualitative description.
Results Views on using the decision support tool could be classiﬁed
into four categories: no need for decision making, need for support,
perceived beneﬁt and practical barriers. For each category, several
underlying themes could be identiﬁed that reﬂect the absence or
presence of prerequisites to successful decision support delivery.
Discussion and conclusion While men and general practitioners gen-
erally have positive attitudes to shared decision making, for both
parties attitudes such as not agreeing that there is a decision to be
made and doubts on the beneﬁcence of using DAs were identiﬁed as
factors that may hinder the use of a DA in clinical practice. Partici-
pants formulated strategies to support the use of DAs, mainly
supplementing DAs with short tools and investing in both training
programmes and large-scale awareness raising of the general public.
Introduction
On the topic of early detection (ED) of prostate
cancer (CaP), shared decision making (SDM) is
advised.1–4 SDM entails patients and clinicians
sharing the best available evidence when facing
a decision and patients being supported to
consider options as well as to achieve informed
preferences.5 Translating this process into prac-
tice is not straightforward, especially when the
evidence related to beneﬁts and harms is
complex, as is the case for ED of CaP.6,7 To sup-
port patients and physicians in SDM, decision
aids (DAs) have been developed. DAs are
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evidence-based tools that prepare people for
participation in making speciﬁc and deliberated
choices among health-care options by providing
them with information and by supporting them
in clarifying and expressing their personal wishes
and values.8
Research shows that DAs have a beneﬁcial
impact on several aspects of decision making:
increasing knowledge, value-based decision
making and SDM.8–15 Realizing these advan-
tages in daily practice requires a DA to be used
outside of the research context. There are, how-
ever, few reports of successful long-term
implementation of DAs in clinical practice. Also,
research on how to successfully organize the
delivery of decision support is scarce.16,17 Obsta-
cles preventing patients and medical specialists
from using DAs have been described and include
general barriers such as time constraints and
more context speciﬁc barriers such as the com-
plexity of the available information.1,2,11,17–21
While our knowledge of these factors improves,
it has yet to be translated into implementation
strategies that meet the needs of care providers
and receivers.18
Our research focuses on factors inﬂuencing
whether a DA on ED of CaP will be used in
daily practice. This topic is characterized by high
stakes and equivalent options that are diﬃcult to
balance, well suited for using a DA. We opted
for an empirical, qualitative research method,
taking into account the richness and variability
of views brought forward by individuals
and groups.22
Methods
Instrument, study design and sample
A qualitative study was conducted, consisting of
group discussions with men aged 50 years and
more eligible for ED of CaP and interviews with
GPs in Flanders, Belgium. Methods follow the
consolidated criteria for reporting qualitative
research (COREQ).23,24 Prior to data collection,
participants had access to a DA on ED of CaP,
‘Making the Choice’, previously developed in
line with international IPDAS-quality criteria
and in collaboration with the GPs participating
in this study.25 This comprehensive instrument
contains information in Dutch on the (dis)ad-
vantages of (not) opting for ED and provides
support in clarifying and communicating prefer-
ences. It was available for participants as a
booklet and as a website.26
To increase study participation and stimulate
future DA implementation, we opted to pur-
posefully limit our study participants to early
adopters, that is potential users who are moti-
vated to adopt an innovation and who can play
an important role in stimulating adoption by
other potential user groups. Therefore, we
selected two participant groups: (i) GPs that
showed an active interest in using DAs in clinical
practice and (ii) men that were interested in or
had questions about ED of CaP. We chose to
include GPs active in both rural and city regions
because the proximity of universities and the
subsequent possibility of frequent involvement
in research implies that GPs of the latter group
may have a diﬀerent view on novel evidence-
based evolutions such as the use of DAs than
GPs of the ﬁrst group.
Together with the Belgian association of GPs
(Domus Medica), we organized information ses-
sions for GPs on SDM and the use of DAs.
Sessions took place throughout Flanders. At the
end of each session, GPs were asked whether
they were interested in testing the DA in clinical
practice. The 36 GPs that answered positively
were contacted for participation in this study.
Eventually, 16 GPs participated in individual
telephone interviews. Non-participating GPs
cited time constraints as a reason for opting out.
In parallel, we contacted 50 clubs and societies
to invite eligible men for participation in our
study. These sociocultural clubs and societies all
bring senior citizens together for various leisure
activities. Five clubs and societies located in the
Northern and central parts of Belgium (Dophei
Vosselaar, KWB Herent, OKRA Vosselaar,
Senioren Leuven and Sint-Sebastiaansgilde Vos-
selaar) responded positively and disseminated
our invitation to their participants. Eligibility
criteria for participating men were as follows: (i)
being 50 years or older and (ii) being interested
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in or having questions about ED of CaP. Men
interested in participation contacted the research
team directly or through the president of their
club. We eventually arrived at a sample of 43
men participating in group discussions that
took place in locations provided by the ﬁve
involved clubs.
All participants received information on the
use of DAs and on the purpose of the study.
Afterwards, all men and GPs who used the DA
gave their verbal and written consent to partici-
pate in the interviews or group discussions. All
participants were informed that they could
withdraw from the study at any time. No ﬁnan-
cial compensation was given. Prior to interviews
(GPs) and group discussions (men), participants
were asked to complete a questionnaire to collect
demographical data as well as data concerning
medical practice (GPs) or decision-making
characteristics (men) (Box 1).
Data collection and analysis
All ﬁve group discussions (men) and 16 individ-
ual telephone interviews (GPs) were conducted
in October 2013. Group discussions involved
5–13 participants and lasted about 120 min.
Individual interviews with GPs lasted about
30 min. Using a semi-structured discussion
guide, the interviews and group discussions pro-
gressed from broad, open-ended questions to
narrower questions with speciﬁc probes to clar-
ify issues if needed.22 All interviews and group
discussions were conducted by AE, a junior
biomedical researcher with experience in con-
ducting qualitative research. AE was supported
Box 1. Characteristics of participating GPs and men
Characteristics of participating GPs Participants (n = 16)* Characteristics of participating men Participants (n = 43)
Gender Year of birth
Male, n 6 Mean 1951
Female, n 9 Range 1938–1964
Year of birth Partner relation
Mean (range) 1964 Partner relation, n 42
Range 1946–1977 No partner relation, n 1
Number of years practicing Education
Mean 23.3 High school graduate or less, n 23
Range 5–38 College graduate, n 20
Patients per week in consultation Employment status
Mean 98 Employed, n 29
Range 55–150 Unemployed/retired, n 14
Hours in consultation per week Using the Internet †
Mean 35.5 A few times a month, n 1
Range 8–60 About once a week, n 3
How often does a patient show an interest in ED of CaP? More often than once a week, n 36
Less often than once a year, n 1 Did you already receive information on ED of CaP?
More often than once a year, n 0 No, n 17
More often than once a month, n 12 Yes, n 26
More often than once a week, n 2 Preference in decision-making style
Patient (me) alone, n 1
Patient after considering GP opinion, n 20
Patient and GP, n 14
GP after considering patient opinion, n 4
GP alone, n 1
*One GP who participated in the interviews (n = 16) did not fill out the questionnaire.
†Three men did not answer this question.
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in this process by JV, a senior researcher who
assisted in one of the group discussions. Data
collection and analysis were supervised by CVA,
a professor with substantial experience in con-
ducting qualitative research. The interviewer
had not been in contact with the study partici-
pants prior to the start of this study. She
participated in the development of the DA used
in this study and has witnessed the diﬃculties of
implementing these tools in daily practice.
Interviews and group discussions focused on
three major topics: (i) the evaluation of the
instrument and its use in consultation, (ii) factors
that may hinder or facilitate implementation and
the realization of positive eﬀects and (iii) views
on the ED decision (Figure 1). Views of GPs and
men relating to the evaluation of the developed
tool as such will be presented elsewhere. The
topic guide was developed by the research team
and was based on experiences in previous studies
on the development and evaluation of DAs.9,27
The questions were intended to stimulate conver-
sation on the perspectives of men and GPs on
using a DA on ED of CaP. Participants were
encouraged to talk freely about their experiences
and views. It was explained that the purpose of
the interview or group discussion was not to
reach agreement and that there were no ‘bad’
answers or comments. No repeat interviews were
carried out. The focus groups and interviews
were recorded, transcribed verbatim and
managed using NVivo10 software (QSR interna-
tional Pty Ltd., Doncaster Australia). Field notes
made during the interviews and group
discussions were used to inform data analysis. At
several points during each interview or group dis-
cussion, the interviewer presented a brief
summary of the main ideas and asked
participants whether they would like to make
changes or additions. Data were reported anony-
mously to maintain conﬁdentiality.
Qualitative description was used to analyse
and report the data collected.28 In a ﬁrst step of
thematic analysis, the most important topics and
concepts were deﬁned by open coding of each
group discussion and interview separately, soon
Figure 1 Basic interview and focus group
schedule.
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after it had taken place. Each information unit
of the transcripts was examined for emergent
themes in relation to the issues explored and
labelled accordingly. We identiﬁed in vivo codes
and explored ideas for the advancement of more
abstract codes. As further data were analysed,
each transcript was revisited and the coding was
revised. The labels assigned to the ideas emerg-
ing from the transcripts were brought together,
inductively categorized and reﬁned through an
iterative process. After thematic analysis by AE,
the accounts of GPs and men were compared to
assess what we could learn from their diﬀerent
perspectives. During the whole process of analy-
sis, whenever it was unclear how transcripts
should be coded, this was resolved through team
discussions. The sample size was suﬃcient to
reach theoretical saturation as the ﬁnal group
discussions and interviews did not change the
study themes.
Results
We identiﬁed four categories related to using the
DA: (i) no need for decision making, (ii) need
for support, (iii) perceived beneﬁt and (iv) prac-
tical barriers. All categories contain several
underlying themes. All categories were identiﬁed
for GPs and men alike. All categories and
themes are described below alongside relevant
data extracts.
No need for decision making
While in each group discussion at least one man
mentioned that ED of CaP has both beneﬁts
and drawbacks, men generally reported no need
for decision support because they felt there was
no decision to be made. Men highlighted the
beneﬁts of ED and saw no reason not to test.
They also admitted being worried about CaP or
about staying healthy in general. Several men
said that their partners advised them to get
tested. GPs, on the other hand, generally
reported that there is no decision to be made.
They did not favour ED of CaP because, to
them, it has too many drawbacks and too
few advantages.
You just have to look at it step by step and start
with the beginning – not being worried yet and
thinking ‘what if?’ . . . . The next time I have a
blood test, I’ll have the PSA value determined and
then we’ll see what the next steps are and how we
can deal with it. At that point you can still make a
decision on what to do with this information.
Thinking about these things now is way too soon.
[Group discussion men 2]
The aspects of overtreatment and making men
worried. . . I am reluctant. You do not have to
leave everything up to fate, but it has to be useful.
You should not create too much unrest in people.
The collateral damage should not be too high and
in this case, I think it is. [Interview GP 1]
The diﬀerent views of men and GPs led to
diﬀerent expectations or goals concerning ED
of CaP. Speciﬁcally, the protesting attitude of
men led them to expect their GPs to test them
proactively. GPs reported being aware of these
expectations, but also mentioned that it would
be better not to bring up ED of CaP during the
consultation to avoid inadvertently giving men
the idea to get tested. Some GPs discussed how
they felt thwarted in their eﬀorts to keep silent
about this topic by the urologists and partners
who advice men to get tested.
On the level of the PSA test and the rectal exam,
which have no negative consequences really, . . . I
think the decision is not diﬃcult. I go to the doctor
every year . . . to get a checkup and each year I get
a rectal exam and sometimes a PSA test. I think it
is normal that [the GP] does this, just like it is for
cholesterol and blood pressure. [Group discussion
men 1]
What’s often the case is that their family or friends
tell them that they should get tested for CaP. Urol-
ogists sometimes say that as well. Then you’re left
without backing, as a GP. [Interview GP 9]
When men discussed how their GPs did not
spontaneously bring up ED of CaP, the overall
sentiment was one of indignation. Some men
and GPs described how men would ask their GP
to test them for CaP when he did not do so
spontaneously. Confronted with these expecta-
tions and questions, many GPs admitted testing
men despite their misgivings, either habitually
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and spontaneously or only in response to a
direct question.
First man: ‘For every blood test, there is a form on
which the GP checks the boxes for [all the tests
that need to be done]. Well, check the box for this
test. And that’s it. Second man (indignant): I have
had to ask my GP, because otherwise he didn’t
check the box! . . . . I think it should be [checked].
[ . . . ] First man: Maybe that is something you
researchers need to work towards, with GPs: “If
you have a patient that is older than 50, you
should always order a PSA test when you do a
blood test.”’ [Group discussion men 2]
There are patients who really want to know. . . . I
do think that my patients expect it of me . . . . that
I meet their expectations . . . . Men are willing to
listen to my reservations about testing, but in the
end they want it [to be tested]. [Interview GP 14]
While men and GPs did express how they prefer
SDM in general, men were not eager to partici-
pate in decision making on ED of CaP – a
feeling expressed by men and acknowledged by
GPs. Men furthermore mentioned in most group
discussions that they do not consider this deci-
sion to be important and that they do not like to
talk about CaP. While some GPs did mention
how they inform men on the topic of ED of CaP
and involve them in decision making, it became
apparent that GPs and men currently generally
do not engage in SDM on ED of CaP
First man: It touches on the manliness of men. . . . .
Second man: With these possible side eﬀects of
impotence and incontinence . . . . Third man: it is a
delicate business. First man: First you have a man
and the consequence could be that he is no longer
a man, and that’s why there is a taboo. [Group
discussion men 3]
The PSA test, for most men, is like ‘I want it’, or ‘I
don’t want it’. I do not have the impression that
there are many men who ﬁrst want to read about
it, and think about it and deliberate about it.
Probably there are other topics for which it is true
that patients want to think and read about it.
[Interview GP 13]
Need for support
Whereas the participating GPs and men gener-
ally reported that they experience no need for
decision making, their accounts did show that
both parties experience a need for support.
Men generally expressed a need for support in
communicating about ED of CaP with their
GPs. Both men and GPs perceived ED of CaP
as a diﬃcult topic on which men lack under-
standing. Both parties expressed a need for
patient-centred information. In addition, GPs
expressed a need for support in the process of
informing men on ED of CaP. In line with
their generally positive attitude towards testing,
in all group discussions men pointed out that
it would be great if there would be a tool that
encourages testing. GPs, on the other hand,
mentioned that there is a need for neutral DAs
that reach men before strong positive percep-
tions of testing are formed and a decision
is made.
It is good that [the DA] will be there – because
otherwise you’re 100% dependent on what your
GP will tell you. Also, on the internet you’ll only
ﬁnd contradictory information that doesn’t help
you very much. So I think it’s very good [that it
exists]. [Group discussion men 5]
Of course, [ED of CaP] is a diﬃcult topic. You
have positive and negative test results and then
you conduct another test and it can again be posi-
tive or negative and then you can either treat or
not treat. There is this duality in everything associ-
ated with it. [Interview GP 6]
Perceived benefit
GPs and men indicated that DAs could have
several eﬀects and evaluated these eﬀects diﬀer-
ently. Members of both parties mentioned that
the DA could lead to either more or less testing.
A decrease in testing due to DA use was gener-
ally perceived as harmful by men and as
advantageous by GPs, while a potential increase
in testing was generally perceived as advanta-
geous by men, but as harmful by GPs.
I was wondering, when I was reading it: Won’t
there be people who say: ‘all those disadvantages!’
and then withdraw . . . It’s going to have down-
sides, people are going to say: ‘For now,
everything is all right; I’m not going to rouse the
sleeping giant!’ . . . . I’m afraid that some people
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might say: ‘What am I getting into? I might be
worse oﬀ than when I started!’ [Group discussion
men 4]
Well, I believe that if a man would be informed
beforehand [on the disadvantages of testing], that
this could have a good, positive inﬂuence in that it
would lead to less testing. [Interview GP 5]
In addition, on the topic of SDM, some men
and GPs were convinced that using the DA
could foster communication, while others dis-
agreed. GPs mentioned that using the DA could
reduce time investment for SDM. On the topic
of information, men and GPs reported that the
DA could help users to understand the complex
nature of ED of CaP. Furthermore, men
described the tool as a good source of informa-
tion and GPs stated that the tool would support
them in their role as information giver. While
some men mentioned that using a DA could
make it easier to arrive at a decision, other men
and GPs felt that using the DA would make it
harder to make a decision.
Practical barriers
GPs discussed they often experience time pres-
sure in daily practice. Men acknowledged this
and mentioned that time constraints might
hinder DA use. Both parties described how using
short tools aimed at fostering SDM in a time-
eﬃcient manner alongside or instead of more
comprehensive DAs, during or outside of the
consultation, could address this barrier to
DA use.
To what extent do GPs still have the time? Because
I think they experience a lack of time. To have a
conversation on the topic with every patient over
the age of 50 – I don’t think they can just say: ‘I
am going to talk about it with every 50-year-old’.
[Group discussion men 2]
There could be a summary or ﬁche . . . on our
desks. If a man comes with a question, we can go
over these points. . . . If somebody really wants to
know more, then you can refer to the website and
then you can tell him to have a look at it in his
own time. If somebody says that he really doesn’t
want all the information and just asks you to do
the test . . . well, you have provided some informa-
tion. [Interview GP 8]
Furthermore, many men and GPs pointed out
that they have no experience in using DAs
and that this might hinder DA use. GPs
advised to organize training sessions to sup-
port them in using DAs. In addition, some
GPs and men doubted whether men would be
capable of using DAs. Both parties pointed
out that it may be challenging for patients to
search for an online DA and to use it eﬃ-
ciently. To address this potential barrier to
DA use, men advised in all group discussions
to ask GPs to deliver the DA to interested
men. Yet, some GPs pointed out that this
might be diﬃcult to achieve given the time
pressure. A solution to this problem men-
tioned by men and GPs alike was to provide
a short folder or poster in the waiting room.
However, several men pointed out that this
does not guarantee that all men ﬁnd the DA
since not all men regularly visit their GP.
Alternatively, men and GPs described how it
would be helpful if men’s awareness on the
existence of DAs and where to ﬁnd them
could be increased by large-scale awareness-
raising campaigns.
Giving GPs the opportunity to practice with [the
DA] so that they can browse it quickly. . . . For
example during LOK meetings [i.e. periodically
organized meetings for physicians as part of per-
manent education], . . . Practical training, concrete:
A patient sits in front of you, this is his question,
he asks for a blood test, for a PSA test, how are
you going to deal with this? [Interview GP 4]
I think you should [increase awareness] by using
the media. There are these shows on the television
like X [informative program] where they raise
issues such as [using DAs] – maybe they can focus
on this topic, for once. So that it is brought out in
the open [Men GD 4]
Discussion
In this study, we explored the views of men and
GPs on using a DA on ED of CaP, allowing us
to identify factors inﬂuencing its use in clinical
practice. Four categories of adoption factors
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were identiﬁed: (i) no need for decision making,
(ii) need for support, (iii) perceived beneﬁt and
(iv) practical applicability.
On the topic of ED of CaP, it became clear
that many GPs and men experienced no need for
decision making. Moreover, the opposing atti-
tudes of men and GPs to ED of CaP lead to a
clash of expectations. Men expected to get tested
and reacted indignantly when their GP did not
do so spontaneously while GPs remarked that it
is diﬃcult for them to deal with men’s unques-
tioningly positive attitude towards testing. In the
process of SDM, it may occur that both GPs
and men bring their opinions and values into the
consultation. When preferences of GPs and men
diﬀer, as in this case, this may negatively aﬀect
their relationship, both parties’ feelings and the
likelihood of achieving true SDM – certainly
when men are unlikely to openly disagree with
their GPs.29
Yet, in general, GPs and men did express a
need for support in communication, understand-
ing information and information giving. In fact,
both parties admitted that men are currently
strongly under- or misinformed on ED of CaP.
Because ED in truth is a complex topic with
advantages and disadvantages that need to be
weighed in decision making, men’s unquestion-
ingly positive attitude towards testing is
indicative of mis- or underinformation.1,30 As
ED has long been portrayed in an unquestion-
ingly positive way in Belgian general media, this
misinformation may in part be explained by pre-
vious exposure to protesting advertising. With
regard to DA implementation, misinformation
may hinder DA uptake by reinforcing the opin-
ion that there is no decision to be made. Without
care providers and users agreeing that a balanc-
ing act is in order when considering a speciﬁc
medical topic, neither party will see any merit in
doing a balancing act together. Indeed, views on
the potential beneﬁt of using the DA were
mixed. To tackle misconceptions and foster
informed decision making, using DAs is a valid
approach. Yet, the results of this study make it
clear that it is diﬃcult to achieve eﬀective use of
DAs when both parties initially feel there is no
decision to be made.8
The accounts of GPs and men showed that
whether tests are conducted is often strongly
inﬂuenced by the patients’ desire to get tested.
Since many men have an uninformed positive
attitude towards testing, this may result in tests
being ordered for men who would not have
opted for ED if they would have been more cor-
rectly and fully informed on the topic.31 In
addition, the DA may reach men when they have
already decided in favour of testing, thus limit-
ing its potential impact on the decision or
decision-making process. As such, the lack of
information explains why many men experi-
enced no need for decision making – a barrier to
DA use – and why there is a need for support to
put the prevailing misconceptions right. As a
consequence, it becomes important to research
means to provide information to men in a way
that is not inﬂuenced by misinformation as a
barrier to information giving. Essentially, this
would imply providing information in a way
that is less dependent on men’s desire to access
the information, such as providing information
on a large scale in general media.
On a practical level and in accordance with
prior research, our results indicate that the prac-
tical applicability of DAs is severely curtailed by
time constraints20 To address this barrier, men
and GPs repeatedly proposed to opt for short
tools that can be used in a time-eﬃcient manner
during the consultation and can either replace or
complement comprehensive DAs. Several
research groups have already experimented with
short decision support tools.32–34 An example is
the recent development of Option Grids: short
one-page tools that can be used during consulta-
tion to optimize the SDM process.32 Prior
research about clinical topics such as breast can-
cer or head and neck cancer has shown that
using Option Grids can contribute to SDM and
can support GPs in delivering information.35,36
Research also shows that interventions targeting
patients and health-care professionals are more
promising than those targeting one or the
other.14 Additionally, in Belgium, DAs are still
novelties, unfamiliar to most health profession-
als and patients. This lack of experience can be
addressed by information and training sessions
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aimed at GPs on using DAs eﬃciently.19
Research shows that multifaceted interventions
that include both eﬀorts to educate health-care
professionals and the use of DAs are promising
in promoting the adoption of SDM in clinical
practice.15 On the patients’ side, our study high-
lights the importance of increasing patients’
awareness on the existence of DAs and where to
ﬁnd them.
This study has some limitations. Firstly, it
focuses on the use of a DA in one speciﬁc com-
plex medical context by participants who were
interested in using a DA or in ED of CaP and
who had the cognitive abilities to understand
and discuss the decision aspects. The speciﬁc
themes identiﬁed in this study may not be pre-
sent as such in other medical contexts or in
diﬀerent user groups. Yet, we do believe that the
broad categories of no need for decision making,
need for support, mixed feelings on potential
beneﬁt and practical applicability also aﬀect the
implementation of DAs in other decisional
contexts. Secondly, the recruitment strategy
employed does not allow for providing informa-
tion on the number of eligible men that chose
not to participate to the study and why.
Thirdly, since it proved unfeasible to organize
group discussions because of time constraints,
we conducted telephone interviews with GPs.
Both methods may lead to a diﬀerent depth and
width of insight in the participants’ views and
experiences, which may have inﬂuenced our
results. Also, interviewing about a care innova-
tion is susceptible to social desirability bias.
However, participants were reminded explicitly
that they could freely speak their mind. An
important strength of this study is that both men
and GPs had access to a DA that was speciﬁcally
designed for them, which allowed for focused
and informed communication on one topic and
resulted in a broad overview of factors inﬂuenc-
ing the eﬀective use of decision support tools.
Future research should focus on the extent to
which the lack of need for decision making, per-
ceived beneﬁt and practical barriers inﬂuence
DA implementation. Also, research should be
done on a DA development strategy that takes
the pre-existing preferences and attitudes of the
target audience into account. We believe that the
DA development process should be preceded by
an assessment of pre-existing attitudes and
potential practical barriers to DA use.
Conclusion
The use of DAs on ED of CaP is inﬂuenced by
multiple adoption factors. A lack of need for
decision making and passive role preferences
hinder patient participation in decision making.
Yet, both GPs and men indicate a need for infor-
mational and communicative support. At the
same time, the perceived time investment associ-
ated with using a DA and a lack of experience
hinder the use of DAs. To overcome barriers to
the use of a DA, we follow the recommendations
of men and GP and call for an increased focus
on the development and practical evaluation of
short decision support tools that can be used in
a time-eﬃcient manner during the consultation.
Yet, to achieve successful DA implementation
we recommend that changes be made not only
on the level of the tools used, but also on an atti-
tudinal level. This calls for health professionals
and patients to be supported in using tools and
to be informed on aspects of the subject matter
of the tool and on SDM. Training programmes
for health professionals that are provided in an
accessible, time-eﬃcient way should be an inte-
gral part of any decision support strategy.
Additionally, large-scale awareness raising can
set patients’ misconceptions right and can
increase patients’ awareness on the existence of
DAs and where to ﬁnd them.
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